Jaguar Health (JAGX) Revenue Growth (3y) (2018 - 2026)
Jaguar Health (JAGX) Revenue Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 50.07% |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 7.94% |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | 4.47% |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | 79.44% |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 54.05% |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 666.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 666.59% |
| Dec 31, 2025 | 365.84% |
| Sep 30, 2025 | -0.53% |
| Jun 30, 2025 | 0.66% |
| Mar 31, 2025 | 380.16% |
| Dec 31, 2024 | 19.04% |
| Sep 30, 2024 | 71.61% |
| Jun 30, 2024 | 92.91% |
| Mar 31, 2024 | 24.85% |
| Dec 31, 2023 | -3.71% |
| Sep 30, 2023 | 500.36% |
| Jun 30, 2023 | 472.50% |
| Mar 31, 2023 | -62.23% |
| Dec 31, 2022 | -72.31% |
| Sep 30, 2022 | 47.67% |
| Jun 30, 2022 | 19.63% |
| Mar 31, 2022 | -76.74% |
| Dec 31, 2021 | 9.23% |
| Sep 30, 2021 | -18.40% |
| Jun 30, 2021 | -24.59% |